Free Trial

Privia Health Group (PRVA) Competitors

Privia Health Group logo
$20.07 -0.06 (-0.30%)
(As of 12/20/2024 05:31 PM ET)

PRVA vs. HIMS, GH, OPCH, SHC, VCYT, BTSG, LFST, SGRY, CON, and ARDT

Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry.

Privia Health Group vs.

Privia Health Group (NASDAQ:PRVA) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

In the previous week, Hims & Hers Health had 20 more articles in the media than Privia Health Group. MarketBeat recorded 29 mentions for Hims & Hers Health and 9 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.60 beat Hims & Hers Health's score of 0.48 indicating that Privia Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Privia Health Group
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
11 Very Positive mention(s)
5 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Privia Health Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Privia Health Group$1.72B1.40$23.08M$0.10200.70
Hims & Hers Health$1.24B4.61-$23.55M$0.4459.55

Hims & Hers Health has a net margin of 8.19% compared to Privia Health Group's net margin of 0.75%. Hims & Hers Health's return on equity of 10.97% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Privia Health Group0.75% 2.02% 1.21%
Hims & Hers Health 8.19%10.97%8.29%

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 14.2% of Privia Health Group shares are owned by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Privia Health Group has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500.

Privia Health Group received 26 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 74.71% of users gave Privia Health Group an outperform vote while only 38.61% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Privia Health GroupOutperform Votes
65
74.71%
Underperform Votes
22
25.29%
Hims & Hers HealthOutperform Votes
39
38.61%
Underperform Votes
62
61.39%

Privia Health Group currently has a consensus price target of $24.80, indicating a potential upside of 23.57%. Hims & Hers Health has a consensus price target of $22.80, indicating a potential downside of 12.98%. Given Privia Health Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe Privia Health Group is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
3.00
Hims & Hers Health
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.41

Summary

Privia Health Group beats Hims & Hers Health on 11 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRVA vs. The Competition

MetricPrivia Health GroupHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$2.41B$867.07M$5.06B$9.08B
Dividend YieldN/A1.90%4.84%4.21%
P/E Ratio200.7232.20102.6717.15
Price / Sales1.403.751,121.74116.80
Price / Cash83.5725.1441.3037.88
Price / Book3.902.924.744.78
Net Income$23.08M-$5.79M$119.11M$225.60M
7 Day Performance-4.25%-4.93%-1.86%-1.21%
1 Month Performance-5.22%-4.89%11.37%3.09%
1 Year Performance-14.56%226.77%30.22%16.48%

Privia Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRVA
Privia Health Group
2.9014 of 5 stars
$20.07
-0.3%
$24.80
+23.6%
-12.6%$2.41B$1.72B200.721,102High Trading Volume
HIMS
Hims & Hers Health
3.3829 of 5 stars
$30.95
+3.1%
$21.43
-30.8%
+214.3%$6.76B$872M70.251,046Analyst Forecast
Insider Trade
News Coverage
GH
Guardant Health
4.1067 of 5 stars
$34.92
+0.5%
$40.60
+16.3%
+25.6%$4.31B$692.26M-8.201,779Positive News
OPCH
Option Care Health
4.861 of 5 stars
$23.46
-0.1%
$30.14
+28.5%
-29.9%$3.99B$4.78B19.747,802Positive News
SHC
Sotera Health
3.5786 of 5 stars
$12.98
-1.3%
$16.08
+23.9%
-20.0%$3.68B$1.05B52.603,000Positive News
VCYT
Veracyte
4.0132 of 5 stars
$43.25
+0.1%
$41.13
-4.9%
+49.0%$3.35B$361.05M-288.13790Positive News
BTSG
BrightSpring Health Services
2.3113 of 5 stars
$18.94
+2.0%
$18.50
-2.3%
N/A$3.30B$10.59B-71.3835,000Analyst Forecast
Positive News
LFST
LifeStance Health Group
1.7047 of 5 stars
$7.77
+8.4%
$8.70
+12.0%
-0.3%$2.97B$1.21B-29.509,325Positive News
Gap Up
SGRY
Surgery Partners
3.2417 of 5 stars
$22.08
+8.4%
$36.56
+65.6%
-33.8%$2.81B$2.74B-42.4213,500
CON
Concentra Group Holdings Parent
N/A$21.52
+5.0%
$28.50
+32.4%
N/A$2.74B$1.88B0.0011,000Gap Up
ARDT
Ardent Health Partners
N/A$16.85
+1.0%
$21.82
+29.5%
N/A$2.41B$5.41B0.0024,200Analyst Forecast
Positive News

Related Companies and Tools


This page (NASDAQ:PRVA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners